Session Details

F062 Controversies in Acne and Rosacea

Sun, Mar 9, 1:00 PM - 3:00 PM
Valencia Ballroom A
2 CME Available Forum ARS CCP
View Map Launch ARS

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

In this session, we will discuss current controversies around acne and rosacea management, with a focus on evidence base surrounding benzene exposure in benzoyl peroxide products, hormonal therapy and contraception, antibiotic stewardship, and dietary interventions. This session is directed to practicing general dermatologists with practical tips on navigating these controversial topics in patient encounters.

This activity has been approved by the American Board of Dermatology (ABD) for up to 20 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.

LEARNING OBJECTIVES

1.

Discuss controversies surrounding benzene exposure with benzoyl peroxide treatment for acne and rosacea

2.

Discuss controversies surrounding diet and dietary intervention with acne and rosacea treatment

3.

Discuss controversies surrounding contraception, emergency contraception, and antibiotic stewardship in acne and rosacea treatment

SCHEDULE

5:00 PM

Benzene in benzoyl peroxide treatment in acne & rosacea

Christopher Bunick, PhD, MD, FAAD

5:30 PM

Contraception in acne & rosacea

Andrea L. Zaenglein, MD, FAAD

6:00 PM

Antibiotic prescribing and stewardship in acne & rosacea

Howa Yeung, MD, FAAD

6:30 PM

Diet and dietary interventions in acne & rosacea

Lauren Kole, MD, FAAD

SPEAKERS

Christopher Bunick, PhD, MD, FAAD

Christopher Bunick, PhD, MD, FAAD

Lauren Kole, MD, FAAD

Lauren Kole, MD, FAAD

Howa Yeung, MD, FAAD

Howa Yeung, MD, FAAD

Andrea L. Zaenglein, MD, FAAD

Andrea L. Zaenglein, MD, FAAD

SPEAKER DISCLOSURES

Christopher Bunick, PhD, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Advisory Boards - South Beach Symposium – Advisory Board(Fees); Almirall – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Consultant (1099 relationship)(Fees); Daiichi Sankyo – Investigator(Grants/Research Funding); Dermatology Times (MMM MultiMedia Medical, LLC) – Advisory Board(Fees); Dermsquared – Speaker/Faculty Education(Fees); Eli Lilly – Consultant (1099 relationship)(Fees); LEO Pharma, US – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); LiVDerm – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Palvella Therapeutics – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Regeneron – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Teladoc Health, Inc. – Consultant (1099 relationship)(Fees); Timber Pharmaceuticals – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);

Lauren Kole, MD, FAAD

Biogen – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding);

Howa Yeung, MD, FAAD

American Academy of Dermatology – Independent Contractor(Fees); American Acne & Rosacea Society – Investigator(Grants/Research Funding); Department. of Veterans Affairs – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); JAMA – Independent Contractor(Fees); National Eczema Association – Investigator(Grants/Research Funding); National Institutes of Health – Investigator(Grants/Research Funding); Sanofi Genzyme – Advisory Board(Honoraria);

Andrea L. Zaenglein, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Biofrontera AG – Investigator(Grants/Research Funding); Church & Dwight Co., Inc. – Consultant(Fees); Dermavant Sciences, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);